Effectiveness of a tailored return to work program for cancer survivors with job loss: results of a randomized controlled trial
- PMID: 27549145
- DOI: 10.1080/0284186X.2016.1213417
Effectiveness of a tailored return to work program for cancer survivors with job loss: results of a randomized controlled trial
Abstract
Background: Up to 53% of cancer survivors (CSs) experiences job loss during or after treatment. To support CSs with job loss in the Netherlands, a tailored return to work (RTW) program was developed. The objective of this study was to assess the effectiveness of the program on duration until sustainable RTW in CSs with job loss.
Material and methods: This study employed a two-armed (intervention/control) randomized controlled design with one-year follow-up. The primary outcome measure was duration until sustainable RTW. The secondary outcome measures were: rate of RTW, fatigue, quality of life, and participation in society. Descriptive analyses, Kaplan-Meier estimators and Cox regression analyses were conducted.
Results: Participants (N = 171) had a mean age of 48.4 years (SD = 8.6). The majority was female (69%) and breast cancer survivor (40%). The crude hazard ratio (HR) for duration until sustainable RTW was 0.86 (95% CI 0.46-1.62; p = 0.642). In the adjusted model, the intervention group had a slight, but statistically non-significant, improvement in duration until sustainable RTW compared to the control group (HR 1.16; 95% CI 0.59-2.31; p = 0.663). The program did not have any significant effects on secondary outcome measures.
Conclusion: As the tailored RTW program did not demonstrate a statistically significant effect on duration until sustainable RTW in CSs with job loss, implementation of the program in its current form is not recommended.
Similar articles
-
Return to Work Interventions for Cancer Survivors: A Systematic Review and a Methodological Critique.Int J Environ Res Public Health. 2019 Apr 14;16(8):1343. doi: 10.3390/ijerph16081343. Int J Environ Res Public Health. 2019. PMID: 31014004 Free PMC article.
-
Return to work in sick-listed cancer survivors with job loss: design of a randomised controlled trial.BMC Cancer. 2015 Feb 18;15:63. doi: 10.1186/s12885-015-1051-1. BMC Cancer. 2015. PMID: 25886150 Free PMC article. Clinical Trial.
-
Offering a tailored return to work program to cancer survivors with job loss: a process evaluation.BMC Public Health. 2016 Sep 6;15(1):940. doi: 10.1186/s12889-016-3592-x. BMC Public Health. 2016. PMID: 27600542 Free PMC article.
-
Predictors for earlier return to work of cancer patients.J Cancer Surviv. 2018 Apr;12(2):169-177. doi: 10.1007/s11764-017-0655-7. Epub 2017 Oct 26. J Cancer Surviv. 2018. PMID: 29076003 Free PMC article.
-
Return to work in European Cancer survivors: a systematic review.Support Care Cancer. 2018 Sep;26(9):2983-2994. doi: 10.1007/s00520-018-4270-6. Epub 2018 May 29. Support Care Cancer. 2018. PMID: 29845421
Cited by
-
Return to Work Interventions for Cancer Survivors: A Systematic Review and a Methodological Critique.Int J Environ Res Public Health. 2019 Apr 14;16(8):1343. doi: 10.3390/ijerph16081343. Int J Environ Res Public Health. 2019. PMID: 31014004 Free PMC article.
-
Non-medical interventions to enhance return to work for people with cancer.Cochrane Database Syst Rev. 2024 Mar 5;3(3):CD007569. doi: 10.1002/14651858.CD007569.pub4. Cochrane Database Syst Rev. 2024. PMID: 38441440 Free PMC article.
-
Cancer survivors and adverse work outcomes: associated factors and supportive interventions.Br Med Bull. 2023 Apr 5;145(1):60-71. doi: 10.1093/bmb/ldac028. Br Med Bull. 2023. PMID: 36372773 Free PMC article. Review.
-
[Determinants in the quality of life of breast cancer survivors].Aten Primaria. 2025 Mar 17;57(9):103253. doi: 10.1016/j.aprim.2025.103253. Online ahead of print. Aten Primaria. 2025. PMID: 40101412 Free PMC article. Spanish.
-
Effectiveness of a mobile-based return to work program for decent return to work, fatigue, stress, and quality of working life among cancer survivors.J Cancer Surviv. 2025 Apr;19(2):713-727. doi: 10.1007/s11764-024-01570-x. Epub 2024 May 21. J Cancer Surviv. 2025. PMID: 38769245
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials